Citation Impact
Citing Papers
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
2017 Standout
Identification of a Primary Target of Thalidomide Teratogenicity
2010 StandoutScience
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
2012 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Modified DNA Aptamer That Binds the ( R )-Isomer of a Thalidomide Derivative with High Enantioselectivity
2007
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
Chimerism of the Transplanted Heart
2002 Standout
Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus
1999
Glutamine and the preservation of gut integrity
1993 Standout
Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients
1998
Hydroxychloroquine for the treatment of chronic graft-versus-host disease
2000
IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation
2003
Cutaneous Graft-versus-Host Disease
1998
Chronic graft-versus-host disease: clinical manifestation and therapy
2001
The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children
1998
2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines
2000
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Interventions with Family Caregivers of Cancer Patients: Meta-Analysis of Randomized Trials
2010
Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte.
1994
Quality of life in 244 recipients of allogeneic bone marrow transplantation
2000
Drug-Induced Hepatotoxicity
2003 Standout
Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers
2004
Quality of Life Instruments for Caregivers of Patients With Cancer
2002
Response to thalidomide therapy in refractory chronic graft-versus-host disease
2000
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
1995 Standout
Early Phase I/II Trials with Gemtuzumab Ozogamicin (Mylotarg®) in Acute Myeloid Leukemia
2002
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
2004 Standout
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
2002 Standout
A structure-based computational workflow to predict liability and binding modes of small molecules to hERG
2020 StandoutNobel
Chronic graft-versus-host disease
2003 Standout
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Etoposide (VP 16-213) induced hepatitis. Report of three cases following standard-dose treatments
1991
Fibroblast growth factor signalling: from development to cancer
2010 Standout
An evaluation of the quality of life among long-term survivors of breast cancer
1996
Outcomes among 562 Recipients of Placental-Blood Transplants from Unrelated Donors
1998 Standout
Detection of minimal residual disease
2001
Inflammatory Bowel Disease
2002 Standout
Graft-versus-host disease
2009 Standout
PATHOPHYSIOLOGY AND TREATMENT OF GRAFT-VERSUS-HOST DISEASE
1999
Combined immunophenotyping and FISH with sex chromosome-specific DNA probes for the detection of chimerism in epidermal Langerhans cells after sex-mismatched bone marrow transplantation
1996
Circos: An information aesthetic for comparative genomics
2009 Standout
Chemotherapy Compared with Autologous or Allogeneic Bone Marrow Transplantation in the Management of Acute Myeloid Leukemia in First Remission
1998
Publication bias in clinical research
1991 Standout
Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease
2000
Long-Term Results of Autologous Stem Cell Transplantation for Primary Refractory or Relapsed Hodgkin’s Lymphoma
2006
Graft-versus-Host Disease as Adoptive Immunotherapy in Patients with Advanced Hematologic Neoplasms
1989
Hematopoietic Stem-Cell Transplantation
2006 Standout
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia
2001
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
Bone Marrow Transplantation
1994
Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies.
1994
An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease
1999
Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an eastern cooperative oncology group trial (E4995)
2004
Outcomes of transplantation with matched-sibling and unrelateddonor bone marrow in children with leukaemia
1997
Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: A southwest oncology group study (SWOG‐9500)
2007
Associations Between End-of-Life Discussions, Patient Mental Health, Medical Care Near Death, and Caregiver Bereavement Adjustment
2008 Standout
The biology and therapy of adult acute lymphoblastic leukemia
2003
A review of autologous hematopoietic cell transplantation
2000 Nobel
Quality criteria were proposed for measurement properties of health status questionnaires
2006 Standout
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
1995 Standout
Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease
2001
Cancer as an evolutionary and ecological process
2006 Standout
A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation
2001
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Amyotrophic Lateral Sclerosis
2001 Standout
Presentation of Epstein-Barr virus latency antigens to CD8+, interferon-γ-secreting, T lymphocytes
1999 StandoutNobel
Initial Treatment of Aggressive Lymphoma with High-Dose Chemotherapy and Autologous Stem-Cell Support
2004
Cyclosporine-Induced Hypertension After Transplantation
1994
Symptoms and Suffering at the End of Life in Children with Cancer
2000 Standout
The thalidomide saga
2007
Bone Marrow Transplantation
1993
Fatigue in Breast Cancer Survivors: Occurrence, Correlates, and Impact on Quality of Life
2000 Standout
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Salvage therapy with thalidomide in multiple myeloma patients relapsing after autologous peripheral blood stem cell transplantation.
2001
Functional Nucleic Acid Sensors
2009 Standout
IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation
2003
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia [see comments]
1995 Standout
Validity of the McGill Quality of Life Questionnaire in the palliative care setting: a multi-centre Canadian study demonstrating the importance of the existential domain
1997
Caregiver Burden
2014 Standout
Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte
2005 Standout
The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development
2011
Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma
2006 Standout
Model study detecting breast cancer cells in peripheral blood mononuclear cells at frequencies as low as 10(-7).
1995
Quality of life in ALS depends on factors other than strength and physical function
2000
Prognostic factors in aggressive non-Hodgkin's lymphoma: who has "high- risk" disease?
1994
Malignancies After Hematopoietic Stem Cell Transplantation: Many Questions, Some Answers
1998
Improved survival in multiple myeloma and the impact of novel therapies
2007 Standout
Survival Benefit of High-Dose Therapy in Poor-Risk Aggressive Non-Hodgkin’s Lymphoma: Final Analysis of the Prospective LNH87–2 Protocol—A Groupe d’Etude des Lymphomes de l’Adulte Study
2000
Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors
2000
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Clinical and Metabolic Efficacy of Glutamine-supplemented Parenteral Nutrition after Bone Marrow Transplantation
1992
Cancer treatment and survivorship statistics, 2016
2016 Standout
A Randomized, Controlled Trial of Prophylactic Ganciclovir for Cytomegalovirus Pulmonary Infection in Recipients of Allogeneic Bone Marrow Transplants
1991
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
Treatment of Primary Progressive Hodgkin’s and Aggressive Non-Hodgkin’s Lymphoma: Is There a Chance for Cure?
2000
The biology and treatment of acute lymphoblastic leukemia in adults
1995
Malignancies After Hematopoietic Stem Cell Transplantation: Many Questions, Some Answers
1998
Bone-Marrow Ablation and Allogeneic Marrow Transplantation in Acute Leukemia
1980
Thalidomide for treatment of patients with chronic graft-versus-host disease
2000
Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation
2001
GITR Activation Induces an Opposite Effect on Alloreactive CD4+ and CD8+ T Cells in Graft-Versus-Host Disease
2004 StandoutNobel
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
2014 Standout
World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997
1999 Standout
Marrow transplantation for acute nonlymphoblastic leukemia in first remission using fractionated or single-dose irradiation
1982 StandoutNobel
Hodgkin's lymphoma
2003
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Treatment of Chronic Graft-Versus-Host Disease With Clofazimine
1997
Total parenteral nutrition and cancer clinical trials
1986
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Cytokine-induced radiation protection and sensitization
1996
Works of GM Schmidt being referenced
Importance of bone marrow cytogenetic evaluation before autologous bone marrow transplantation for Hodgkin's disease.
1991
High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.
1994
In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remission.
1996
High-dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non M3 acute myelogenous leukemia: impact of cytogenetics on achieving a complete remission
2000
The meaning of quality of life for bone marrow transplant survivors. Part 1. The impact of bone marrow transplant on quality of life.
1992
Genetic markers in human bone marrow transplantation.
1980
Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies [published erratum appears in Blood 1987 Jun;69(6):1789]
1987
Bone marrow transplantation for patients with Philadelphia chromosome- positive acute lymphoblastic leukemia
1987
High-dose chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy during first complete remission in adult patients with poor-risk aggressive lymphoma: a pilot study [see comments]
1992
Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission
1993
The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone
1995
Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remission
1991
Thalidomide as salvage therapy for chronic graft-versus-host disease
1995
Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission
1993
Bone marrow transplantation for patients with Philadelphia chromosome- positive acute lymphoblastic leukemia
1987
High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: results in 85 patients with analysis of prognostic factors
1995
Parenteral nutrition in bone marrow transplant recipients
1986